Fla. Admin. Code Ann. R. 64B16-31.012 - Collaborative Practice Certification: HIV Postexposure Prophylaxis Certification Required Submissions
(1) Prior to
ordering and dispensing any HIV postexposure prophylaxis drugs under section
465.1861, F.S., a certified
pharmacist shall submit a copy of the collaborative practice agreement to the
Board pursuant to 465.1861(4),
F.S. The Pharmacist shall submit the completed agreement to the Board Office
through the pharmacist's online licensure account at
http://flhealthsource.gov or via
U.S. Mail to 4052 Bald Cypress Way, Bin C-04, Tallahassee, FL 32399. In the
event of an addendum to the material terms of an existing collaborative
pharmacy practice agreement, the pharmacist shall maintain a copy of the
addendum and the initial agreement. Material terms shall be defined as those
terms enumerated in Section
465.1861(4)(a),
F.S.
(2) Any pharmacy in which a
pharmacist is ordering and dispensing any HIV postexposure prophylaxis drugs
pursuant to section 468.1861, F.S., must submit an access-to-care plan
complying with section
465.1861(7),
F.S., to the Board and Department prior to any pharmacist providing services at
that location. The pharmacy shall submit the access-to-care plan to the Board
and Department through the pharmacy's online licensure account at
http://flhealthsource.gov or via
U.S. Mail to 4052 Bald Cypress Way, Bin C-04, Tallahassee, FL 32399. Each
access-to-care plan shall contain the enumerated requirements of section
465.1861 (7)(b), the name of
pharmacy, the pharmacy's physical location, and the pharmacy's permit number.
All pharmacies in which a pharmacist is providing services pursuant to section
465.1861, F.S., shall submit an access-to-care-plan on February 28, 2025, and
each February 28 thereafter in the same manner as outlined for the initial
submission.
(3) If a pharmacy fails
to submit its annual access-to-care plan the matter shall be immediately
referred to the Department of Health, Consumer Services Unit as a complaint for
consideration of disciplinary action pursuant to section
456.073, F.S. and
465.1861(7)(a),
F.S. In the event a pharmacy submits a non-compliant access-to-care plan, the
Board shall issue a notice of non-compliance outlining the alleged deficiencies
and provide it to the prescription department manager or consultant pharmacist
of record. The pharmacy shall then be given thirty (30) days from receipt of
the Notice to submit a corrected access-to-care-plan. If the corrected
access-to-care plan is determined to be deficient, or if the pharmacy fails to
submit a corrected access-to-care plan, the matter shall be referred to the
Department of Health, Consumer Services Unit as a complaint for consideration
of disciplinary action pursuant to section
456.073, F.S. and
465.1861(7)(a),
F.S.
Notes
Rulemaking Authority 465.1861 FS. Law Implemented 465.1861 FS.
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.